Updated:
Suncoast Ventures
Suncoast Ventures was founded in July 2021 by Managing Partner Genevieve LeMarchal alongside a group of engineers, scientists, and entrepreneurs who...
Suncoast Ventures
Suncoast Ventures was founded in July 2021 by Managing Partner Genevieve LeMarchal alongside a group of engineers, scientists, and entrepreneurs who wanted a venture firm designed specifically for healthcare startups. LeMarchal previously ran three cohorts of health tech and medtech companies at Expert Dojo and served as a General Partner at FoundersPad VC Fund II. The firm operates from San Diego with a distributed team of venture partners who carry dual operating backgrounds — practicing clinicians, medical device CEOs, and former McKinsey and Accenture health practice leaders. The firm targets early-stage companies solving what it calls "$1B healthcare problems hiding in plain sight." Its portfolio spans digital health, medtech, medical AI, and consumer health, with confirmed positions in maternal remote monitoring platform Bloomlife, AI-powered virtual care manager Welby Health, and noninvasive fetal pulse oximeter Raydiant Oximetry. Additional named holdings include GritWell in functional medicine, Tenzr Health in gamified physical therapy, and Next Life Sciences in male contraception. Geographically, portfolio companies cluster in California, the Pacific Northwest, Texas, and New Jersey, with emerging-market exposure through Talamus Health's Africa-based care coordination platform. Suncoast Ventures lists 17 professionals including five venture partners, an advisor, and a scientific advisory focused on AI and machine learning. The team integrates clinical operators — Dr. Ray Costantini, who built and sold digital health company Bright.MD, and Hal Walbrink, whose product development firm Xinetix has supported companies generating over $1 billion in annual product sales. In Q1 2025, the firm added five new portfolio companies including dental consumer brand The Gleamery, care coordination startup ClinNEXUS, and AI-enabled practice management tool Welby Health. No parallel investment vehicles or philanthropic foundations are disclosed. The firm's architecture is unusual among seed-stage healthcare investors: nearly every venture partner is a current or former healthcare operator rather than a career financier. LeMarchal explicitly designed Suncoast as a "next generation VC firm" with in-house clinical, engineering, and commercialization expertise that deploys alongside syndicate co-investors such as the American Heart Association, Mayo Clinic, and the Bill and Melinda Gates Foundation. The structure effectively bundles an operator network into a venture platform, blurring the line between accelerator, advisory, and fund.
General information
Firm type
Private Equity
Year founded
2021
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Diego
Corporate office
San Diego, CA, United States
Principals
Genevieve LeMarchal
Managing Partner
Hal Walbrink
Venture Partner
Ray Costantini
Venture Partner
Tammy Mahaney
Venture Partner
Russ Nash
Venture Partner
Charla Triplett
Advisor
Joe Geraci
Scientific Advisor — AI, ML, Quantum
Sector focus
Frequently asked questions
Who runs investment decisions at Suncoast Ventures?
Managing Partner Genevieve LeMarchal leads investment decisions. She built the firm's investment model after running Expert Dojo's healthcare accelerator and serving as a GP at FoundersPad VC Fund II. The venture partner bench includes former operators like Dr. Ray Costantini (Bright.MD) and Hal Walbrink (Xinetix), but the firm's website does not detail a formal investment committee structure.
How does Suncoast Ventures source proprietary deal flow?
Suncoast's sourcing appears driven by its operator-heavy team. Venture partners include practicing clinicians, medical device entrepreneurs, and former health system executives whose networks span hospitals, universities, and portfolio companies. The firm's website lists no systematic inbound channels, but explicitly instructs startups not to use the contact form for pitches, suggesting a referral-based or proactive sourcing model.
Is Suncoast Ventures structured as a family office or a venture firm?
Suncoast Ventures operates as a traditional early-stage venture firm, not a family office. It was founded in 2021 by a group of engineers and entrepreneurs. The firm does not disclose its limited partners or fund structure publicly, but its portfolio composition — 17 named companies with institutional co-investors like Mayo Clinic and the Gates Foundation — aligns with a standard venture capital fund model.
Does Suncoast participate in fund commitments or only direct deals?
Based on disclosed information, Suncoast engages only in direct investments, not fund-of-fund commitments. Every named portfolio company on the firm's website is a direct operating company. The firm co-invests alongside other venture funds and institutional investors, suggesting a direct-deal syndication approach rather than allocating capital to other fund managers.
What investment stages does Suncoast typically target?
Suncoast targets early-stage healthcare companies from seed to growth. The firm's own description mentions early stage, seed, and startup phases, while its portfolio includes companies ranging from pre-revenue therapeutics to growth-stage digital health platforms. Specific round participation is not disclosed per company, but co-investors like Techstars and Cedars-Sinai Accelerator indicate seed-stage activity.
Which sectors does Suncoast explicitly avoid?
Suncoast has not published explicit exclusion criteria. Its portfolio is entirely healthcare-focused, with no disclosed investments outside digital health, medtech, medical AI, consumer health, and life sciences. The firm's stated thesis — "$1B healthcare problems hiding in plain sight" — and its clinical operator team composition strongly indicate a singular healthcare mandate, effectively excluding sectors like fintech, enterprise software, or climate.
Does Suncoast maintain philanthropic structures, and how are they separated?
Suncoast has not disclosed any philanthropic foundation, donor-advised fund, or impact vehicle. Some venture partners, like Tammy Mahaney, have personal involvement in global health missions and community volunteering, but these activities appear separate from the firm's investment operations. No formal philanthropic allocation or structure is referenced on the firm's website.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: